Key facts
- Intelon Optics’s last known valuation is $45.0M (Nov 2020).
- It has raised $15.4M; the latest was Later Stage VC in Aug 2025.
- Notable investors include National Institutes of Health, IMM Investment, InterVest, Kakao Ventures, NextCorps Luminate — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Intelon Optics
- ·The full record, as it builds
Funding rounds
No funding rounds for Intelon Optics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Intelon Optics
Developer of a biomechanical imaging device designed to facilitate individualized treatment of eye diseases. The company's device helps in the next-generation point-by-point bio-mechanical imaging of eye structures extending from the cornea to the posterior part of the globe, enabling eye care professionals to use a wide range of novel diagnostic and surgical services.
- Sector
- Healthcare
- HQ
- Woburn, MA, United States
- Founded
- 2011
- Employees
- 22
- Website
- intelon.com/
- Ownership
- Privately Held (backing)
Intelon Optics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Intelon Optics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Intelon Optics in its N-PORT filings yet. We sweep new filings monthly.